---
title: "Caliway Biopharmaceuticals Incurs NT$589 Million Loss in January"
date: "2025-02-07 18:11:27"
summary: "Caliway Biopharmaceuticals'  loss attributable to owners amounted to NT$588.8 million, or NT$4.12 per basic share in January. The pharmaceuticals company did not provide comparative year-ago figures. Operating revenue accumulated for the period amounted to NT$44.4 billion, according to a Friday Taiwanese bourse filing."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Caliway Biopharmaceuticals' loss attributable to owners amounted to NT$588.8 million, or NT$4.12 per basic share in January.

The pharmaceuticals company did not provide comparative year-ago figures.

Operating revenue accumulated for the period amounted to NT$44.4 billion, according to a Friday Taiwanese bourse filing.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:G2465087:0/)
